Generated automatically from the NAFDAC register, WHO alerts and community data as of today. Not medical advice — always follow your doctor or pharmacist.
From the official U.S. FDA label for Determine HIV Early Detect, the active ingredient registered with NAFDAC.
For the treatment of acne
Acne Treatment
For external use only. When Using This Product Skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only one medication should be used. Do not use if you are allergic to the dressing or any of its components.
Add the expiry date printed on your pack for a full Trust Score — or look up uses, side effects and cheaper generics.
Determine HIV Early Detect contains HIV Test (NA), as na, according to its NAFDAC registration record.
Yes. Determine HIV Early Detect is listed on the NAFDAC register under registration number 03-6286, and its registration is active as of 5 November 2026.
No WHO falsified or substandard medical product alert currently matches Determine HIV Early Detect in our automatically synced alert list.
Run a free authenticity scan with the NAFDAC number 03-6286, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.
For the treatment of acne (Summarised from the official U.S. FDA label for Determine HIV Early Detect. Always follow your doctor or pharmacist.)
Reviews are personal experiences from RxVerify users, not medical advice. Report side effects to your doctor and to NAFDAC.